Li-Fraumeni Syndrome in Breast Cancer: Development of Theranostic Probes on Variation of P53
Article Sidebar
Main Article Content
Abstract
Li-Fraumeni Syndrome (LFS) is a hereditary condition characterized by a high predisposition to various cancers due to mutations in the p53 protein. Effectively targeting and treating this syndrome requires early detection and personalized treatment according to one’s specific nucleotide sequence. With the use of various forms of theranostics, LFS can be treated, increasing life expectancy; however, there is no absolute cure that could immediately end this syndrome. This paper delves into three different theranostic approaches: Gendicine (rAd-p53), Phesgo, and gold nanoshell poly(D, L-lactic-co-glycolic acid) nanoparticles (PLGA NPs). While each approach has limitations, PLGA nanoparticles exhibit advantages that outweigh their drawbacks, making it an attractive solution. This proposal will describe improvements to PLGA nanoparticles, which are a promising area of research for the development of new LFS treatments.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Bhushan, A., Gonsalves, A., & Menon, J. U. (2021). Current State of Breast Cancer Diagnosis, Treatment, and Theranostics. Pharmaceutics, 13(5), 723. https://doi.org/10.3390/pharmaceutics13050723
Coughlan, L. (2020). Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines [Review of Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines].
Deng, X., Shao, Z., & Zhao, Y. (2021). Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy. Advanced Science, 8(3), 2002504. https://doi.org/10.1002/advs.202002504
Engeland, K. (2022). Cell cycle regulation: p53-p21-RB signaling. Cell Death & Differentiation, 29(5), 1–15. https://doi.org/10.1038/s41418-022-00988-z
Frebourg, T., Lagercrantz, S. B., Oliveira, C., Magenheim, R., Evans, D. G., & Genturis, T. E. R. N. (2020). Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes. European Journal of Human Genetics, 28(10), 1379. https://doi.org/10.1038/s41431-020-0638-4
Gao, G., Sun, X., & Liang, G. (2021). Nanoagent‐promoted mild‐temperature photothermal therapy for cancer treatment. Advanced Functional Materials, 31(25), 2100738
Gao, Q., Zhang, J., Gao, J., Zhang, Z., Zhu, H., & Wang, D. (2021). Gold Nanoparticles in Cancer Theranostics. Frontiers in Bioengineering and Biotechnology, 9. https://doi.org/10.3389/fbioe.2021.647905
Gasco, M., Shami, S., & Crook, T. (2002). The p53 pathway in breast cancer. Breast Cancer Research, 4(2). https://doi.org/10.1186/bcr426
Izumori, A., Takebe, K., & Sato, A. (2010). Ultrasound findings and histological features of ductal carcinoma in situ detected by ultrasound examination alone. Breast Cancer, 17, 136-141.
Kajon, A. E. (2019). Adenovirus Genome [Review of Adenovirus Genome, by K. R. Spindler].
Kratz, C. P., Freycon, C., Maxwell, K. N., Nichols, K. E., Schiffman, J. D., Evans, D. G., Achatz, M. I., Savage, S. A., Weitzel, J. N., Garber, J. E., Hainaut, P., & Malkin, D. (2021). Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set. JAMA Oncology, 7(12), 1800. https://doi.org/10.1001/jamaoncol.2021.4398
Kuijs, V. J. L., Moossdorff, M., Schipper, R. J., Beets-Tan, R. G. H., Heuts, E. M., Keymeulen, K. B. M. I., ... & Lobbes, M. B. I. (2015). The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review. Insights into imaging, 6, 203-215.
Li, S.-D., & Huang, L. (2010). Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting. Journal of Controlled Release, 145(3), 178–181. https://doi.org/10.1016/j.jconrel.2010.03.016
Loibl, S.; Gianni, L. HER2-positive breast cancer. Lancet 2017, 389, 2415–2429
Marvalim, C., Datta, A., & Soo Chin Lee. (2023). Role of p53 in breast cancer progression: An insight into p53 targeted therapy. Theranostics, 13(4), 1421–1442. https://doi.org/10.7150/thno.81847
Mendonça, S. A., Lorincz, R., Boucher, P., & Curiel, D. T. (2021). Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. Npj Vaccines, 6(1). https://doi.org/10.1038/s41541-021-00356-x
Morris, E. A. (2002). Breast cancer imaging with MRI. Radiologic Clinics, 40(3), 443-466.
Nami, B., Maadi, H., & Wang, Z. (2018). Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer. Cancers, 10(10), 342. https://doi.org/10.3390/cancers10100342
Qi, J., Lu, Y., & Wu, W. (2012). Absorption, disposition and pharmacokinetics of solid lipid nanoparticles. Current Drug Metabolism, 13(4), 418-428.
Qi, L., Li, G., Li, P., Wang, H., Fang, X., He, T., & Li, J. (2023). Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology. Genes & Diseases, 101155. https://doi.org/10.1016/j.gendis.2023.101155
Rebolj, M., Assi, V., Brentnall, A., Parmar, D., & Duffy, S. W. (2018). Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis. British journal of cancer, 118(12), 1559-1570.
Schneider, K., Zelley, K., Nichols, K. E., & Garber, J. (1993). Li-Fraumeni Syndrom. Europe PMC. http://europepmc.org/abstract/MED/20301488
ScienceFacts. (2020, November 6). Cell Cycle: Definition, Phases, and Diagram. Science Facts. https://www.sciencefacts.net/cell-cycle.html
Sengupta, A., Azharuddin, M., Al-Otaibi, N., & Hinkula, J. (2022). Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases. Vaccines, 10(4), 505. https://doi.org/10.3390/vaccines10040505
Song, Y., Xu, X., MacRenaris, K. W., Xue Qing Zhang, Mirkin, C. A., & Meade, T. J. (2009). Multimodal Gadolinium‐Enriched DNA–Gold Nanoparticle Conjugates for Cellular Imaging. Angewandte Chemie International Edition, 48(48), 9143–9147. https://doi.org/10.1002/anie.200904666
Tazin, F., Kumar, H., Israr, M. A., Omoleye, D., & Orlang, V. (2022). Li-Fraumeni Syndrome: A Rare Genetic Disorder. Cureus. https://doi.org/10.7759/cureus.29240
Venkatachalam, M. A., & Rennke, H. G. (1978). The structural and molecular basis of glomerular filtration. Circulation research, 43(3), 337-347.
Xie, J., Lee, S., & Chen, X. (2010). Nanoparticle-based theranostic agents. Advanced Drug Delivery Reviews, 62(11), 1064–1079. https://doi.org/10.1016/j.addr.2010.07.009
Xu, L., Wan, C., Du, J., Li, H., Liu, X., Yang, H., & Li, F. (2017). Synthesis, characterization, and in vitro evaluation of targeted gold nanoshelled poly(d,l-lactide-co-glycolide) nanoparticles carrying anti p53 antibody as a theranostic agent for ultrasound contrast imaging and photothermal therapy. Journal of Biomaterials Science. Polymer Ed., 28(4), 415–430. https://doi.org/10.1080/09205063.2016.1277828
Yang, Q., & Lai, S. K. (2015). Anti‐PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 7(5), 655-677.
Yang, Y., Zhu, W., Dong, Z., Chao, Y., Xu, L., Chen, M., & Liu, Z. (2017). 1D Coordination Polymer Nanofibers for Low-Temperature Photothermal Therapy. Advanced Materials, 29(40), 1703588. https://doi.org/10.1002/adma.201703588